Construction and expression of a recombinant antibody-targeted plasminogen activator.

AUTOR(ES)

Schnee, J M

RESUMO

Covalent linkage of tissue-type plasminogen activator (t-PA) to a monoclonal antibody specific for the fibrin beta chain (anti-fibrin 59D8) results in a thrombolytic agent that is more specific and more potent than t-PA alone. To provide a ready source of this hybrid molecule and to allow tailoring of the active moieties for optimal activity, we have engineered a recombinant version of the 59D8-t-PA conjugate. The rearranged 59D8 heavy chain gene was cloned and combined in the expression vector pSV2gpt with sequence coding for a portion of the gamma 2b constant region and the catalytic beta chain of t-PA. This construct was transfected into heavy chain loss variant cells derived from the 59D8 hybridoma. Recombinant protein was purified by affinity chromatography and analyzed with electrophoretic transfer blots. These revealed a 65-kDa heavy chain-t-PA fusion protein that is secreted in association with the 59D8 light chain in the form of a 170-kDa disulfide-linked dimer. Chromogenic substrate assays showed the fusion protein to have 70% of the peptidolytic activity of native t-PA and to activate plasminogen as efficiently as t-PA. In a competitive binding assay, reconstituted antibody was shown to have a binding profile similar to that of native 59D8. Thus, by recombinant techniques, we have produced a hybrid protein capable of high-affinity fibrin binding and plasminogen activation.

Documentos Relacionados

• Antibody-Targeted Lethal Photosensitization of Porphyromonas gingivalis
• Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
• Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.
• Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.
• Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo